Symposium Pediatric and Adult Neuromuscular Diseases

In light of the rapidly evolving treatment landscape for neuromuscular diseases, we would like to discuss with you this year the possibilities we have and challenges we face measuring the outcome of our patients that benefit from such therapies

  • What are relevant outcomes used in studies?
  • Can we transfer them to our clinical practice and are they suitable for a day-to-day work?
  • What are possible future perspectives?
  • Colleagues from different medical specialities, professions, and also other Swiss reference centers have accepted to share their knowledge.


 Coordination: Prof. O. Scheidegger, Prof. A. Klein, Prof. U. Fischer, Prof. P. Latzin

Program

How do we measure the treatment outcome of patients suffering from neuromuscular diseases in clinical studies and practice?

14.00–14.05

Welcome and opening remarks

Urs Fischer, Philipp Latzin

14.05–14.35

In pediatric patients

Bettina Henzi,Christina Schläppi

14.35–15.05

Clinically and using PROMs

Paolo Ripellino

15.05–15.35

Using neurophysiological techniques

Alex Vicino

15.35–16.00

Coffee break

 

16.00–16.30

Using imaging

Olivier Scheidegger

16.30–17.00

Using pneumological outcomes like lung function and sleep parameters

Christian Horvath

17.00–17.30

Using wearables/nearables

Tobias Nef

17.30

Closing remarks followed by an aperitif